Home › NDC Lookup › RxCUI directory › RxCUI 705129

Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray — RxCUI 705129

RxNorm drug concept · Semantic clinical drug
RxCUI 705129 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI705129
Official nameNitroglycerin 0.4 MG/ACTUAT Mucosal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asNTG 0.4 MG/ACTUAT Mucosal Spray; nitroglycerin 400 MCG/ACTUAT Mucosal Spray; nitroglycerin 400 MCG/ACTUAT Oral Spray; nitroglycerin 400 MCG/ACTUAT Sublingual Spray; TNG 0.4 MG/ACTUAT Mucosal Spray
FDA products mapped8
Package NDCs mapped12
Reported Medicaid activity (SDUD)680 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nitroglycerin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — the nitroglycerin patch works too slowly for that. It's designed to prevent angina from happening in the first place, not to stop an attack once it starts. You should still ha...
  • Can I use this patch to stop chest pain that's already started?
  • Yes, the nightly break is essential. Wearing the patch around the clock causes your body to stop responding to it — this is called tolerance — and the patch can completely lose its...
  • Do I really have to take the patch off every night? What happens if I just leave it on?
📖 Read our full Nitroglycerin Transdermal Patch guide →

🕸️ Concept Web — How Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray RxCUI 705129

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nitroglycerin 4917
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nitrolingual 151177
    • NitroMist 705130
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nitroglycerin Mucosal Spray 705128
    • Nitroglycerin Mucosal Product 1159827
    • Nitroglycerin Mucosal Spray [Nitrolingual] 995018
    • Nitroglycerin Mucosal Spray [NitroMist] 705132
    • Nitrolingual Mucosal Product 1184457
    • NitroMist Mucosal Product 1183938
    • Mucosal Spray 346163
    • Mucosal Product 1151129
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Nitroglycerin 0.4 MG/ACTUAT 330744
    • Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray [Nitrolingual] 995019
    • Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray [NitroMist] 705133
    • Nitroglycerin 0.4 MG/ACTUAT [Nitrolingual] 564666
    • Nitroglycerin 0.4 MG/ACTUAT [NitroMist] 705131

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nitroglycerin 0.4 MG/ACTUAT SCDC · 330744
  • Nitroglycerin Mucosal Spray SCDF · 705128
  • Nitroglycerin Mucosal Product SCDG · 1159827

Brand-Name Concepts

  • Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray [Nitrolingual] SBD · 995019
  • Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray [NitroMist] SBD · 705133
  • Nitroglycerin 0.4 MG/ACTUAT [Nitrolingual] SBDC · 564666
  • Nitroglycerin 0.4 MG/ACTUAT [NitroMist] SBDC · 705131
  • Nitroglycerin Mucosal Spray [Nitrolingual] SBDF · 995018
  • Nitroglycerin Mucosal Spray [NitroMist] SBDF · 705132
  • Nitrolingual Mucosal Product SBDG · 1184457
  • NitroMist Mucosal Product SBDG · 1183938
  • Nitrolingual BN · 151177
  • NitroMist BN · 705130

📦 FDA Products & Package NDCs

8 products · 12 package NDCs
12 package NDCs map to RxCUI 705129 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21724-0100-41 1 BOTTLE, SPRAY in 1 CARTON (21724-100-41) / 200 SPRAY in 1... NITROLINGUAL INDEPENDENCE PHARMACEUTICALS, LLC 2024-12-02
21724-0100-50 1 BOTTLE, SPRAY in 1 CARTON (21724-100-50) / 60 SPRAY in 1... NITROLINGUAL INDEPENDENCE PHARMACEUTICALS, LLC 2024-12-02
28595-0120-49 1 BOTTLE in 1 CARTON (28595-120-49) / 60 SPRAY in 1 BOTTLE NITROGLYCERIN LINGUAL Allegis Pharmaceuticals, LLC 2019-07-01
45802-0210-01 1 BOTTLE in 1 CARTON (45802-210-01) / 60 SPRAY in 1 BOTTLE nitroglycerin lingual Padagis Israel Pharmaceuticals Ltd 2013-09-20
45802-0210-02 1 BOTTLE in 1 CARTON (45802-210-02) / 200 SPRAY in 1 BOTTLE nitroglycerin lingual Padagis Israel Pharmaceuticals Ltd 2013-09-20
51662-1393-01 1 BOTTLE in 1 CARTON (51662-1393-1) / 60 SPRAY in 1 BOTTLE NITROGLYCERIN LINGUAL HF Acquisition Co LLC, DBA HealthFirst 2019-10-09
51662-1423-01 60 SPRAY in 1 BOTTLE (51662-1423-1) NITROGLYCERIN LINGUAL HF Acquisition Co LLC, DBA HealthFirst 2019-10-09
51662-1519-01 1 BOTTLE in 1 CARTON (51662-1519-1) / 60 SPRAY in 1 BOTTLE NITROGLYCERIN LINGUAL HF Acquisition Co LLC, DBA HealthFirst 2020-06-25
51662-1519-02 60 SPRAY in 1 BOTTLE (51662-1519-2) NITROGLYCERIN LINGUAL HF Acquisition Co LLC, DBA HealthFirst 2020-06-25
51662-1672-01 1 BOTTLE, SPRAY in 1 CARTON (51662-1672-1) / 60 SPRAY in 1... NITROGLYCERIN HF Acquisition Co LLC, DBA HealthFirst 2024-12-02
66993-0241-41 1 BOTTLE, SPRAY in 1 CARTON (66993-241-41) / 200 SPRAY in 1... Nitroglycerin Prasco Laboratories 2024-12-02
66993-0241-50 1 BOTTLE, SPRAY in 1 CARTON (66993-241-50) / 60 SPRAY in 1... Nitroglycerin Prasco Laboratories 2024-12-02
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (5) · INDEPENDENCE PHARMACEUTICALS, LLC (2) · Padagis Israel Pharmaceuticals Ltd (2) · Prasco Laboratories (2) · Allegis Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$24.0318
Range $17.1456–$24.0318 · middle 50% $17.1456–$24.0318 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.